FDA authorizes first standalone robotic device to draw blood

The U.S. Food and Drug Administration has authorized Aletta as the first standalone robotic device that can draw blood from a patient’s arm. Marketing authorization was granted to Vitestro.

If you liked the article, do not forget to share it with your friends. Follow us on Google News too, click on the star and choose us from your favorites.

If you want to read more Like this articles, you can visit our Science category.

Source

Leave a Reply

Your email address will not be published. Required fields are marked *